Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer.
Koujima T, Tazawa H, Ieda T, Araki H, Fushimi T, Shoji R, Kuroda S, Kikuchi S, Yoshida R, Umeda Y, Teraishi F, Urata Y, Mizuguchi H, Fujiwara T.
Koujima T, et al. Among authors: fushimi t.
Mol Ther Oncolytics. 2020 Mar 31;17:107-117. doi: 10.1016/j.omto.2020.03.016. eCollection 2020 Jun 26.
Mol Ther Oncolytics. 2020.
PMID: 32322667
Free PMC article.